ArticleYonsei medical journal2016

Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.

Juan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.